Back to search

United Kingdom· GB-APID-11382611000001107

Rovamycine 375,000units/5ml syrup

A spiramycin product containing spiramycin, registered in United Kingdom by Imported (France). The same ATC class is registered in 9 of our 19 countries.

ATC J01FA02

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedRovamycine 375,000units/5ml syrupATCJ01FA02REGISTER NO.GB-APID-1138261100000…PACKS LISTED0CHECKEDSeptember 13, 2026

Where it is registered

Spiramycin is registered in 9 of 19 countries.

Countries holding a registration under ATC J01FA02 (spiramycin), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 6 of them publish a price we can compare per daily dose

Spiramycin · ATC J01FA02

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Germany
  • Japan
  • Norwayprice
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Spiramycin
Manufacturer
Imported (France)
Country
United Kingdom (GB)
ATC code
J01FA02
ATC class
Spiramycin
Defined daily dose
3 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

5 interactions on record for spiramycin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Spiramycin · interactions on record

5 records

5 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Spiramycin in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All spiramycin products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Belgium · Rovamycine
  • Czechia · Rovamycine
  • Germany · Rovamycine, Selectomycin
  • Spain · Rovamycine
  • France · Rovamycine, Spiramycine Biogaran
  • Italy · Rovamicina
  • Luxembourg · Rovamycine
  • Latvia · Rovamycine
  • Poland · Rovamycine
  • Portugal · Rovamycine
  • Romania · Rovamycine
  • Slovakia · Rovamycine

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c966ea1f-abe2-468b-bec4-4a42c1be2cbc
GET /v1/drugs/c966ea1f-abe2-468b-bec4-4a42c1be2cbc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "11382611000001107",
  "desc": "Rovamycine 375,000units/5ml syrup (Imported (France))",
  "form": "Oral solution",
  "vpid": "35900311000001105",
  "source": "dmd",
  "vtm_id": "777602007",
  "strength": "75000 unit",
  "substance": "Spiramycin",
  "ingredient": "Spiramycin",
  "supplier_code": "11820511000001100"
}

See everything about spiramycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.